The independent source for health policy research, polling, and news.
261 - 280 of 112,391 Results
Szarama has served as a deputy to director Vinay Prasad, who left the agency Thursday. FDA Commissioner Marty Makary said he expects to make a decision on a permanent replacement in the coming weeks. Plus, the CDC has put state and local health officials on alert about the potential for more measles cases.
Moreover, for people seeking graduate-level degrees to become nurse practitioners or physician assistants, federal loans will be limited to $20,500 annually. The Education Department says the rule, effective July 1, will save taxpayers $409 billion and will reduce student loan debt by $224 billion, Modern Healthcare reports. But several leading medical trade groups have raised concerns about the possible effect on the clinician pipeline.
With the exception of President Donald Trump's advice for pregnant women to steer clear of Tylenol, the radiologist shares the MAHA movement's critical eye toward vaccines and its medical messaging. Meanwhile, the finger-pointing has begun as to why Means' nomination faltered. Plus: Healthcare providers' Social Security numbers have been compromised.
Insurance companies, state officials, and industry analysts are reporting that many more people have abandoned their Obamacare coverage now that they are facing higher long-term costs, The New York Times writes. Adding to the problem: Cigna's absence in 2027 will leave 369,000 members in the lurch, according to media reports.
Today's early morning highlights from the major news organizations.
Each week, KFF Health News compiles a selection of health policy studies and briefs.
Opinion writers discuss these public health matters.
A study by the CDC shows that women are less likely than men to wake up feeling rested, and they have a harder time falling and staying asleep. Thirty percent of adults surveyed sleep fewer than seven hours a night. Also: carbon pollution's effect on the food we eat; ultraprocessed food's link to increased dementia risk; and more.
Unlike other insurance giants, Humana had held off on shrinking benefits up until this point, Modern Healthcare reports. But in a change of events, President and CEO Jim Rechtin announced the company will be streamlining offerings in order to shrink the gap between expenses and federal payments, Modern Healthcare reported.
The unanimous ruling is a victory for First Choice Women’s Resource Centers. The case revolves around First Amendment concerns the center has regarding a subpoena to turn over donor lists and whether the center used misleading practices.
Skinny labeling, Stat explains, is when a generic drugmaker seeks approval to market a drug for a specific use other than those for which the brand-name medicine is prescribed as a way to avoid patent infringement lawsuits. The outcome of the hearing could affect access to generics.
Wednesday's Supreme Court ruling gives Republicans an opportunity to break up Black and Hispanic majority districts for partisan gain, The Washington Post reported. One activist in Louisiana, Press Robinson, who grew up in South Carolina during segregation, predicted that Republicans in Southern states would move aggressively to reshape the political landscape, The New York Times reported. “They are determined to see to it that we don’t have a voice at all,” he said.
On Wednesday, the Department of Justice rolled out dozens of planned changes to federal gun regulations, including rolling back a Biden-era measure that sought to end the "gun show loophole."
Today's early morning highlights from the major news organizations.
Editorial writers delve into these public health topics.
The jury attributed 88% of the fault to the University of Kansas Hospital Authority and 12% of the fault to LivaNova USA Inc., the medtech company that manufactured the device that was used in Stephen Nolte's heart surgery at KU Med. This is one of more than two dozen lawsuits filed against the University of Kansas Hospital Authority and LivaNova, the Kansas City Star reports.
According to the Centers for Disease Control and Prevention, roughly a dozen of the 34 people who became ill are younger than 5. Also in the news: consequences of covid screening; a report on deaths related to hepatitis B and C; the dangers of chatbots and bioterrorism; and more.
FDA staff have expressed concerns about the use of camizestrant to treat metastatic breast cancer and capivasertib for patients with metastatic hormone-sensitive prostate cancer. The Oncologic Drugs Advisory Committee will vote on these two drug applications Thursday.
Despite pushback from some members, the reconstituted Interagency Autism Coordinating Committee also recommended the establishment of safety measures to protect people who wander from their caregivers and to encourage Medicaid to set guidelines for diagnosis and possible health risks, Stat reported.
© 2026 KFF